Young hearts at risk: Unveiling novel factors in myocardial infarction susceptibility and prevention

Ashis Ranjan1, Rajat Agarwal2, Shiv Kumar Mudgal3

  • 1Department of Cardiology, AIIMS Deoghar, Jharkhand, India.

Insights

Acute myocardial infarction (AMI) in young people is rising, with novel risk factors like air pollution and long COVID playing a key role. Understanding these factors is crucial for prevention and reducing mortality.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Acute myocardial infarction (AMI) incidence is increasing in younger populations.
  • Traditional risk factors for AMI are less associated with young patients.
  • Novel risk factors require identification for effective prevention strategies.

Purpose of the Study:

  • To review and compare risk factor profiles in young-onset AMI versus older patients.
  • To investigate novel risk factors, susceptibility, and preventive measures for young AMI.
  • To highlight the need for further research into young AMI and its emerging risk factors.

Main Methods:

  • Review of existing literature on young-onset AMI.
  • Comparison of risk factor profiles across different age groups.
  • Analysis of emerging risk factors and their potential impact.

Main Results:

  • Young-onset AMI is associated with distinct risk factors compared to older individuals.
  • Established inflammatory markers (e.g., lipoprotein (a), dyslipidaemia, long COVID) and emerging factors (e.g., air pollution, periodontitis, stress, energy drinks, drug misuse) are implicated.
  • Comprehensive risk profiles, especially in specific demographics like young South Asians, remain under-evaluated.

Conclusions:

  • Novel risk factors significantly contribute to AMI in the young population.
  • Aggressive management of conventional risk factors and screening for novel markers are essential.
  • Sex- and geography-specific approaches and further prospective studies are needed to address the rising incidence of young AMI.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
635
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77